Pharmaceutical preparations based on active ingredients susceptible to illict administration
申请人:ALTERGON S.A.
公开号:EP1273301A2
公开(公告)日:2003-01-08
The present invention provides oral pharmaceutical preparations unsuitable for illicit administration to victims.
本发明提供了不适合非法给受害者服用的口服药物制剂。
Pharmaceutical preparations based on active ingredients susceptible to illicit administration
申请人:ALTERGON S.A.
公开号:EP1273301B1
公开(公告)日:2006-09-06
Microbial Metabolism of Bornaprine, 3-(Diethylamino)propyl 2-Phenylbicyclo[2.2.1]heptane-2-carboxylate
作者:Sayed A. Elmarakby、Alice M. Clark、John K. Baker、Charles D. Hufford
DOI:10.1002/jps.2600750620
日期:1986.6
Metabolism studies of the anticholinergic drug, bornaprine [3-(diethylamino)propyl2-phenylbicyclo[2.2.1]heptane-2-carboxylate, an epimeric mixture], in rats, dogs, and humans have been conducted previously, but the identities of the metabolites were not established. Using an in vitro microbial system to study the metabolism of bornaprine resulted in the isolation of four metabolites whose structures